UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract P1-07-34: Clinical outcomes of single versus double hormone receptor positive breast cancer patients treated with neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-07-34

2018

Volltextzugriff (PDF)

Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer

The New England journal of medicine, 2004-09, Vol.351 (10), p.963-970

2004

Volltextzugriff (PDF)

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)

Annals of oncology, 2006-06, Vol.17 (6), p.952-956

2006

Volltextzugriff (PDF)

International variability in the reimbursement of cancer drugs by publically funded drug programs

Current oncology (Toronto), 2012-06, Vol.19 (3), p.e165-176

2012

Volltextzugriff (PDF)

Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study

Journal of clinical oncology, 2002-01, Vol.20 (1), p.42-51

Goodwin, P. J.

2002

Volltextzugriff (PDF)

Abstract P4-10-14: Pilot data from the development of the Senior Women's Breast Cancer Clinic at Sunnybrook Odette Cancer Centre

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P4-P4-10-14

2018

Volltextzugriff (PDF)

Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer?

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6037-6042

2005

Volltextzugriff (PDF)

Health-Related Quality of Life and Psychosocial Status in Breast Cancer Prognosis: Analysis of Multiple Variables

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4184-4192

2004

Volltextzugriff (PDF)

Abstract P1-08-24: High tumor RNA disruption is associated with increased survival in patients with locally advanced breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-08-24

2013

Volltextzugriff (PDF)

Changes in Prognosis after the First Postoperative Complication

Medical care, 2005-02, Vol.43 (2), p.122-131

2005

Volltextzugriff (PDF)

Multivariate Matching and Bias Reduction in the Surgical Outcomes Study

Medical care, 2001-10, Vol.39 (10), p.1048-1064

2001

Volltextzugriff (PDF)

Diet and Breast Cancer: Evidence That Extremes in Diet Are Associated With Poor Survival

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2500-2507

2003

Volltextzugriff (PDF)

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

Breast cancer research and treatment, 2002-07, Vol.74 (1), p.65-76

2002

Volltextzugriff (PDF)

Mauna Loa volcano is not a methane source: Implications for Mars

Geophysical research letters, 2006-06, Vol.33 (12), p.L12301-n/a

2006

Volltextzugriff (PDF)

Prognostic factors affecting the natural history of node-negative breast cancer

Breast cancer research and treatment, 2005, Vol.89 (1), p.35-45

2005

Volltextzugriff (PDF)

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group

Journal of clinical oncology, 1996-02, Vol.14 (2), p.422-428

1996

Volltextzugriff (PDF)

Preoperative antibiotics and mortality in the elderly

Annals of surgery, 2005-07, Vol.242 (1), p.107-114

2005

Volltextzugriff (PDF)

Stable isotopic analysis of atmospheric methane by infrared spectroscopy by use of diode laser difference-frequency generation

Applied Optics, 2006-06, Vol.45 (17), p.4136

2006

Volltextzugriff (PDF)

Reductions in tumor RNA integrity associated with clinical response to epirubicin/docetaxel chemotherapy in breast cancer patients

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.6068

2009

Volltextzugriff (PDF)

Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer

Seminars in oncology, 1999-06, Vol.26 (3 Suppl 8), p.21-26

Trudeau, M E

1999

Volltextzugriff (PDF)

Optimizing adjuvant breast cancer chemotherapy: rationale for the MA.21 study

Oncology (Williston Park, N.Y.), 2001-05, Vol.15 (5 Suppl 7), p.7

Trudeau, M E

2001

Volltextzugriff (PDF)

Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model

Annals of surgical oncology, 2000-07, Vol.7 (6), p.416-426

2000

Volltextzugriff (PDF)

Docetaxel (Taxotere) : An overview of first-line monotherapy

Seminars in oncology, 1995-12, Vol.22 (6), p.17-21

TRUDEAU, M. E

1995

Volltextzugriff (PDF)

Ascertaining Prognosis for Breast Cancer in Node-Negative Patients with Innovative Survival Analysis

The breast journal, 2006-01, Vol.12 (1), p.37-47

2006

Volltextzugriff (PDF)

Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin

Journal of clinical oncology, 1997-05, Vol.15 (5), p.1897-1905

1997

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(198)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Abstract P1-07-34: Clinical outcomes of single versus double hormone receptor positive breast cancer patients treated with neoadjuvant chemotherapy

Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)

International variability in the reimbursement of cancer drugs by publically funded drug programs

Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study

Abstract P4-10-14: Pilot data from the development of the Senior Women's Breast Cancer Clinic at Sunnybrook Odette Cancer Centre

Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer?

Health-Related Quality of Life and Psychosocial Status in Breast Cancer Prognosis: Analysis of Multiple Variables

Abstract P1-08-24: High tumor RNA disruption is associated with increased survival in patients with locally advanced breast cancer

Changes in Prognosis after the First Postoperative Complication

Multivariate Matching and Bias Reduction in the Surgical Outcomes Study

Diet and Breast Cancer: Evidence That Extremes in Diet Are Associated With Poor Survival

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

Mauna Loa volcano is not a methane source: Implications for Mars

Prognostic factors affecting the natural history of node-negative breast cancer

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group

Preoperative antibiotics and mortality in the elderly

Stable isotopic analysis of atmospheric methane by infrared spectroscopy by use of diode laser difference-frequency generation

Reductions in tumor RNA integrity associated with clinical response to epirubicin/docetaxel chemotherapy in breast cancer patients

Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer

Optimizing adjuvant breast cancer chemotherapy: rationale for the MA.21 study

Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model

Docetaxel (Taxotere) : An overview of first-line monotherapy

Ascertaining Prognosis for Breast Cancer in Node-Negative Patients with Innovative Survival Analysis

Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin

Suchergebnisse filtern